Sabra Health Care REIT Inc. [SBRA] has traded in a range of $5.55 to $24.95 in the last 1 year. As of this writing, the stock is at $14.71, up 3.08%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, SBRA shares are -1.28% down with the monthly amount drift of -7.02% and seems bad in a long time frame.

On 7, October 2020, Sabra Health Care REIT, Inc. to Participate in NAHCA’s Virtual CNA Staffing Summit. According to news published on Yahoo Finance, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, will be speaking at the NAHCA’s Virtual CNA Staffing Summit: A Conversation Between CNAs and Industry Leaders on the CNA Staffing Crisis on October 20, 2020.

Analyst Birdseye View:

The most recent analyst activity for Sabra Health Care REIT Inc. [NASDAQ:SBRA] stock was on June 23, 2020, when it was Upgrade with a Sector perform rating from Scotiabank, which also raised its 12-month price target on the stock to $15. Before that, on September 02, 2020, Stifel Recapitulated a Hold rating and elevated its amount target to $15. On June 08, 2020, JMP Securities Resumed a Mkt perform rating. On May 18, 2020, Berenberg Upgrade a Buy rating and increased its price target to $15. On March 23, 2020, BofA/Merrill Downgrade an Underperform rating. On February 26, 2020, Mizuho Upgrade a Buy rating and boosted its amount on this stock to $22. On February 05, 2020, Berenberg Initiated a Hold rating and boosted its target amount on this stock to $22.

In the past 52 weeks of trading, this stock has oscillated between a low of $5.55 and a peak of $24.95. Right now, the middling Wall Street analyst 12-month amount mark is $15.75. At the most recent market close, shares of Sabra Health Care REIT Inc. [NASDAQ:SBRA] were valued at $14.71. According to the average price forecast, investors can expect a potential return of 1.97%.

FUNDAMENTAL ANALYSIS

Sabra Health Care REIT Inc. [NASDAQ:SBRA] most recently reported quarterly sales of 151.52 billion, which represented growth of 0.90%. This publicly-traded organization’s revenue is $19,610,971 per employee, while its income is $2,029,294 per employee. This company’s Gross Margin is currently 83.00%, its Operating Margin is 23.10%, its Pretax Margin is +10.86, and its Net Margin is +10.35. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at 1.08, 2.05, 3.45 and 1.12 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 40.88 and the whole liability to whole assets at 39.74. It shows enduring liability to the whole principal at 40.65 and enduring liability to assets at 0.40 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 14.26 points at 1st support level, the second support level is making up to 13.80. But as of 1st resistance point, this stock is sitting at 14.96 and at 15.20 for 2nd resistance point.

Sabra Health Care REIT Inc. [SBRA] reported its earnings at $0.14 per share in the fiscal quarter closing of 6/29/2020. The Analysts for Wall Street were expecting to report its earnings at $0.15/share signifying the difference of -0.01 and -6.70% surprise value. Comparing the previous quarter ending of 3/30/2020, the stated earnings were $0.17 calling estimates for $0.2/share with the difference of -0.03 depicting the surprise of -15.00%.

Now if looking for a valuation of this stock’s amount to sales ratio it’s 6.02, it’s amount to book ratio is 1.26 and showing 23.13 of P/E (TTM) ratio.

Insider Stories

The most recent insider trade was by FOSTER MICHAEL J, Director, and it was the purchase of 9675.0 shares on Mar 16. FOSTER MICHAEL J, the Director, completed a purchase of 3200.0 shares on Mar 16. On Mar 06, Ettl Robert A., Director, completed a sale of 10545.0 shares.